Records containing: Shingles
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-08-14Nudging Patients to Increase Shingles Vaccination
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 2, Randomized, Triple-Blinded, Active-Controlled Study to Assess the Safety and Immunogenicity of an Investigational Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects ≥ 50 Years of Age
-
CLINICAL_TRIALS study record update · 2026-03-27A PHASE 1/2 RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST VARICELLA ZOSTER VIRUS IN HEALTHY INDIVIDUALS
-
CLINICAL_TRIALS study record update · 2025-12-30A Phase Ⅱ, Randomized, Observer-blinded, Parallel-Controlled Clinical Trial to Assess the Immunogenicity and Safety of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
-
CLINICAL_TRIALS study record update · 2025-11-06A Phase 1/2 Randomized, Observer-Blinded, Active-Controlled, Dose, Escalation Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Participants 50 Years of Age and Over
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-30A Randomized, Observer-Blind, Phase 2 Study To Assess the Safety and Immunogenicity of CRV-101 Vaccine Head-To-Head With SHINGRIX® for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
-
CLINICAL_TRIALS study record update · 2025-07-14Nudging Patients to Increase Shingles Vaccination
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 1 Randomized, Double-Blinded, Active-Controlled, 2-Dose Study to Assess the Safety and Immunogenicity of a Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects 50 to 69 Years of Age.
-
CLINICAL_TRIALS study record update · 2024-07-30Systems Biology of Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)
-
CLINICAL_TRIALS study record update · 2024-04-10Immunogenicity of the Recombinant Zoster Vaccine (Shingrix ®) in Multiple Sclerosis Patients Treated With Anti-CD20 Antibodies Compared to Controls- a Phase IV Monocentric Study
-
CLINICAL_TRIALS study record update · 2023-12-27Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
-
CLINICAL_TRIALS study record update · 2023-03-22Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-03-08Phase II, Non-randomized, Open-label Study to Assess the Immunogenicity and Clinical Efficacy of the Recombinant Zoster Vaccine for Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2022-11-07A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 Years
-
CLINICAL_TRIALS study record update · 2022-07-14Post-Licensure Observational Study of the Long-term Effectiveness of ZOSTAVAX™
-
CLINICAL_TRIALS study record update · 2021-06-25Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Nursing Home Residents
-
CLINICAL_TRIALS study record update · 2020-07-08A Comparison of the Immunogenicity and Descriptive Safety of a Live Attenuated Herpes Zoster Vaccine and the Glaxo Smith Kline (GSK) Herpes Zoster Recombinant HZ/su Candidate Vaccine in 50-59 Year Old and 70-85 Year Old Vaccine Recipients
-
CLINICAL_TRIALS study record update · 2020-03-04Valacyclovir in Immunocompromised Children
-
CLINICAL_TRIALS study record update · 2019-12-05Immune Response to Shingles Vaccination
-
CLINICAL_TRIALS study record update · 2018-04-06A Pilot Study Using a Randomized Design to Evaluate the Immunologic Efficacy and Safety of ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
-
CLINICAL_TRIALS study record update · 2018-01-23A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
-
CLINICAL_TRIALS study record update · 2018-01-23A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2017-12-22A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain
-
CLINICAL_TRIALS study record update · 2017-10-13Comparison of Immune Response Induced by Zoster Vaccine According to the Timing of Vaccination After Zoster Illness
-
CLINICAL_TRIALS study record update · 2017-03-15A Double-Blind, Placebo-Controled, Randomized Study to Evaluate Safety, Tolerability, and Immunogenicity After 1 and 2 Doses of Zoster Vaccine